- Industry Solutions
Industry Solutions
From reshaping the quote to cash process, to transforming engagement with channels partners, to achieving excellence in global product launch, Model N enables digital reinvention with industry-specific solutions that maximize revenue.
- Right block
Contact Sales
Ebook
whitepaper
whitepaper
What you need to know, how you can prepare, and when you need to take action.
2025 is the year when much of the legislation set forth in the IRA will take effect, including three key provisions that will heavily impact many pharmaceutical manufacturers: the Manufacturer Discount Program (MDP), the Inflation Rebate Program, and the Medicare Drug Price Negotiation Program (MDPNP).
Challenges and opportunities
This eBook provides important information to help pharma manufacturers gauge the effect of the IRA on their business and develop effective strategies for managing and operating in the sea of regulatory change.
Key takeaways
- Understand the differences between the previously existing Coverage Gap Discount Program and its replacement, the MDP
- Access facts and formulas regarding Medicare Part B and Part rebates under the new Inflation Rebate Program
- See how manufacturers are pushing back on the MDPNP
- Get guidance on how to update your gross-to-net forecasts and accruals
- View a detailed timeline of how and when your team can prepare for effective management and operation under the IRA
2025 State of Revenue Report
The 7th annual State of Revenue Report reveals the power of data and analytics in optimizing life sciences and high-tech revenue. VIEW whitepaper
